Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.
暂无分享，去创建一个
R. Labianca | V. Catalano | R. Berardi | A. Zaniboni | S. Cascinu | F. Loupakis | A. Falcone | M. Scartozzi | A. Mandolesi | I. Bearzi | C. Pierantoni | T. Biscotti | F. Zorzi | A. Quadri